Ligand Pharmaceuticals
LGND
#4132
Rank
โ‚ฌ2.10 B
Marketcap
111,22ย โ‚ฌ
Share price
4.47%
Change (1 day)
108.18%
Change (1 year)

Revenue for Ligand Pharmaceuticals (LGND)

Revenue in 2024 (TTM): โ‚ฌ0.12 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.12 Billion. In 2023 the company made a revenue of โ‚ฌ0.11 Billion a decrease over the revenue in the year 2022 that were of โ‚ฌ0.16 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ligand Pharmaceuticals from 1996 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.12 B4.3%
2023 โ‚ฌ0.11 B-26.31%
2022 โ‚ฌ0.16 B-34.13%
2021 โ‚ฌ0.24 B61.46%
2020 โ‚ฌ0.15 B41.15%
2019 โ‚ฌ0.10 B-51.15%
2018 โ‚ฌ0.21 B86.91%
2017 โ‚ฌ0.11 B13.51%
2016 โ‚ฌ0.10 B57.52%
2015 โ‚ฌ65.77 M23.94%
2014 โ‚ฌ53.06 M49.64%
2013 โ‚ฌ35.46 M49.44%
2012 โ‚ฌ23.72 M2.6%
2011 โ‚ฌ23.12 M30.7%
2010 โ‚ฌ17.69 M-34.89%
2009 โ‚ฌ27.18 M39.11%
2008 โ‚ฌ19.53 M121.26%
2007 โ‚ฌ8.83 M-84.42%
2006 โ‚ฌ56.69 M-59.01%
2005 โ‚ฌ0.13 B18.33%
2004 โ‚ฌ0.11 B4.27%
2003 โ‚ฌ0.11 B21.26%
2002 โ‚ฌ92.44 M6.95%
2001 โ‚ฌ86.44 M66.95%
2000 โ‚ฌ51.77 M27.5%
1999 โ‚ฌ40.61 M172.27%
1998 โ‚ฌ14.91 M-65.76%
1997 โ‚ฌ43.56 M39.73%
1996 โ‚ฌ31.17 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ31.04 B 24,274.05%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ24.55 M-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.41 B 30,056.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ59.62 B 46,708.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ53.09 B 41,586.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.99 B 30,514.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ45.26 B 35,437.69%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.31 B 11,135.56%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.68 B 65,600.71%๐Ÿ‡บ๐Ÿ‡ธ USA